Molecure S.A.
MOC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| - Cash | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| + Debt | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Enterprise Value | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | -100% | – | – | – |
| Gross Profit | PLN 0 | PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | 89.3% | – | – |
| EBITDA | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | -80% | – | – |
| Net Income | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | -116.8% | – | – |
| EPS Diluted | -0.26 | -0.17 | -0.26 | -0.52 |
| % Growth | -52.9% | 34.6% | 50% | – |
| Operating Cash Flow | -PLN 0 | -PLN 0 | PLN 0 | -PLN 0 |
| Capital Expenditures | PLN 0 | PLN 0 | -PLN 0 | -PLN 0 |
| Free Cash Flow | -PLN 0 | -PLN 0 | PLN 0 | -PLN 0 |